3 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 2 | Terminated 2 |
Follow elacestrant: new trials by email Literature Review of elacestrant trials Research Report on elacestrant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer Elacestrant, Onapristone - Breast Cancer | Phase 1 / Phase 2 | Terminated | Context Therapeutics Inc. | 4 | 2022-12-02 | 2026-07-21 |
| Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer Abemaciclib, Elacestrant - Breast Cancer | Phase 1 / Phase 2 | Terminated | Criterium, Inc. | 5 | 2022-04-21 | 2026-03-31 |
| Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms RAD1901, Placebo - Vasomotor Symptoms, Hot Flashes | Phase 2 | Terminated | Radius Pharmaceuticals, Inc. | 139 | 2015-12-01 | 2019-03-13 |
Breast Neoplasms (2) · Hot Flashes (1)
Context Therapeutics Inc. (1) · Criterium, Inc. (1) · Radius Pharmaceuticals, Inc. (1)
United States (3)
Peter Kabos, MD (1)